Literature DB >> 17373898

Tuning inflammation with anti-inflammatory neuropeptides.

Nieves Varela1, Alejo Chorny, Elena Gonzalez-Rey, Mario Delgado.   

Abstract

The immune system is confronted with the daunting task of defending the organism against invading pathogens while at the same time remaining self-tolerant to the body's own constituents and preserving its integrity. The loss of immune tolerance stemming from an unbalance in pro-inflammatory factors versus anti-inflammatory cytokines, or of autoreactive/inflammatory T helper 1 cells versus regulatory/suppressive T cells, results in the breakdown of immune homeostasis and the subsidiary appearance of exacerbated inflammatory and autoimmune diseases. Some neuropeptides have been shown to have anti-inflammatory properties and to participate in maintaining immune tolerance. Here the authors examine the most recent developments in this field and highlight the effectiveness of using neuropeptides in treating several inflammatory and autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373898     DOI: 10.1517/14712598.7.4.461

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  11 in total

1.  Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.

Authors:  Christopher T Petersen; Jian-Ming Li; Edmund K Waller
Journal:  Oncoimmunology       Date:  2017-03-16       Impact factor: 8.110

Review 2.  Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents.

Authors:  Mario Delgado; Doina Ganea
Journal:  Brain Behav Immun       Date:  2008-06-14       Impact factor: 7.217

3.  Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice.

Authors:  Jian-Ming Li; Lauren Southerland; Mohammad S Hossain; Cynthia R Giver; Ying Wang; Kasia Darlak; Wayne Harris; James Waschek; Edmund K Waller
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

4.  VPAC1 overexpression is associated with poor differentiation in colon cancer.

Authors:  Shaohua Liu; Yunjie Zeng; Yunhua Li; Wenying Guo; Jiali Liu; Nengtai Ouyang
Journal:  Tumour Biol       Date:  2014-03-28

5.  Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling.

Authors:  Jian-Ming Li; Christopher T Petersen; Jing-Xia Li; Reema Panjwani; Daniel J Chandra; Cynthia R Giver; Bruce R Blazar; Edmund K Waller
Journal:  Cancer Res       Date:  2016-09-26       Impact factor: 12.701

6.  Mitomycin C-treated dendritic cells inactivate autoreactive T cells: toward the development of a tolerogenic vaccine in autoimmune diseases.

Authors:  Peter Terness; Thilo Oelert; Sandra Ehser; Jing Jing Chuang; Imad Lahdou; Christian Kleist; Florian Velten; Günter J Hämmerling; Bernd Arnold; Gerhard Opelz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

Review 7.  Neuroimmunology: What Role for Autoimmunity, Neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and Adverse Events after Human Papillomavirus Vaccination?

Authors:  Varvara A Ryabkova; Leonid P Churilov; Yehuda Shoenfeld
Journal:  Int J Mol Sci       Date:  2019-10-18       Impact factor: 5.923

Review 8.  Direct and indirect antimicrobial activities of neuropeptides and their therapeutic potential.

Authors:  Daria Augustyniak; Judyta Nowak; Fionnuala T Lundy
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

9.  VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.

Authors:  Jian-Ming Li; Kasia A Darlak; Lauren Southerland; Mohammad S Hossain; David L Jaye; Cassandra D Josephson; Hilary Rosenthal; Edmund K Waller
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

Review 10.  Immunotherapy for Parkinson's disease.

Authors:  Aaron D Schwab; Mackenzie J Thurston; Jatin Machhi; Katherine E Olson; Krista L Namminga; Howard E Gendelman; R Lee Mosley
Journal:  Neurobiol Dis       Date:  2020-01-21       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.